Skip to content

Clinical trials

Observational Pancreatic Intraductal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Intraductal Neoplasms Phase: Observational Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20192
20201
20212
20221
20242
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Not yet recruiting4
Unknown status3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS San Raffaele3
Instituto Ecuatoriano de Enfermedades Digestivas2
Sahlgrenska University Hospital2
Adenocyte, LLC1
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis1
Changhai Hospital1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Huazhong University of Science and Technology1
Hôpital Fribourgeois1
Karolinska University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Intraductal Neoplasms17
Pancreatic Neoplasms8
Pancreatic Cyst5
Pancreatitis, Chronic4
Adenoma, Islet Cell2
Cystadenoma, Serous2
Pancreatic Diseases2
Pancreatic Pseudocyst2
Pancreatitis2
Autoimmune Pancreatitis1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.